EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Elucidating the Pharmacological Basis of Xianling Cifang Granules Against Breast Cancer. A Metabolomic Profiling Study

Yang Wang iD, Rui Yang, Youyang Shi, Sheng Liu

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s530516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Yang Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, People's Republic of China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalAnimalsMiceNetwork PharmacologyBreast NeoplasmsAntineoplastic Agents, PhytogenicMolecular Docking SimulationMetabolomicsFemaleMice, Inbred BALB CDrug Screening Assays, AntitumorFlavonoidsReceptor, Adenosine A3Aldehyde ReductaseReceptor, Adenosine A1Aldo-Keto Reductases

Stichwörter der Autor:innen

UHPLC-Q exactive Orbitrap-MSXianling Cifang granulesmetabolitesnetwork pharmacologyprototypes

Substanzen

Drugs, Chinese HerbalAntineoplastic Agents, PhytogenicicaritinAdora1 protein, mouseAkr1b3 protein, mouseAdora3 protein, mouseFlavonoidsReceptor, Adenosine A3Aldehyde ReductaseReceptor, Adenosine A1

Autor:innen und Institutionen

  • Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, People's Republic of China.
  • China Academy of Chinese Medical Sciences, Suzhou, 215100, People's Republic of China.
  • Shanxi Province Cancer Hospital/Shanxi Hospital Afiliated to Cancer Hospital, Chinese Academy of Medical, Sciences/Cancer Hospital Afiliated to Shanxi Medical University, Shanxi, 030013, People's Republic of China.
  • Graduate School, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.

ORCID-Profile: Yang Wang

Zitieren

APA

Wang, Y., Yang, R., Shi, Y., & Liu, S. (2025). Elucidating the Pharmacological Basis of Xianling Cifang Granules Against Breast Cancer. A Metabolomic Profiling Study. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s530516

Vancouver

Wang Y, Yang R, Shi Y, Liu S. Elucidating the Pharmacological Basis of Xianling Cifang Granules Against Breast Cancer. A Metabolomic Profiling Study. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s530516

BibTeX
@article{Wang2025,
  author = {Wang, Yang and Yang, Rui and Shi, Youyang and Liu, Sheng},
  title = {Elucidating the Pharmacological Basis of Xianling Cifang Granules Against Breast Cancer. A Metabolomic Profiling Study},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s530516}
}
Kostenlos starten →